CoMentis Company

AmCyte develops encapsulated proliferated human islets for transplantation into patients with diabetes. The company specializes in adult stem cell research to treat diabetes with islet replacement therapy.
Technology: Stem Cell
Industry: Regenerative medicine
Headquarters: United States
Founded Date: 2004
Employees Number: 51-100
Funding Status: Late Stage Venture
Investors Number: 14
Total Funding: $107.5M
Last Funding Type: Series E

Register and Claim Ownership